Real World Data on Rituximab Maintenance Therapy After Frontline Immunochemotherapy in Grade 1-3a Follicular Lymphoma

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14775
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma

British Journal of Haematology
Hematology
2018English

OUTCOMES AFTER EARLY TRANSFORMATION (tPOD24) VS. EARLY FOLLICULAR LYMPHOMA PROGRESSION (fPOD24) IN FOLLICULAR LYMPHOMA TREATED WITH FRONTLINE IMMUNOCHEMOTHERAPY

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Grade 3a Follicular Lymphoma Can Be Effectively Controlled With Very Low Dose Radiation Therapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Gene Expression Profiling Reveals a Close Relationship Between Follicular Lymphoma Grade 3A and 3B, but Distinct Profiles of Follicular Lymphoma Grade 1 and 2

Haematologica
Hematology
2018English

Real World Data and the Art of Maintenance Therapy

British Journal of Haematology
Hematology
2018English

The Comparison of De Novo Grade 3 Follicular Lymphoma and Transformed Grade 3 Follicular Lymphoma: Own Data

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2017English

Refractoriness to Immunochemotherapy in Follicular Lymphoma: Predictive Factors and Outcome

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Prognostic Value of Pre-Treatment Pet Scan in Patients With Follicular Lymphoma Receiving Frontline Therapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Immunochemotherapy With Obinutuzumab or Rituximab in Previously Untreated Follicular Lymphoma in the Randomised Phase Iii Gallium Study: Analysis by Chemotherapy Regimen

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy